Enrolling COVID-19 Clinical Trials at Our Center:
Vaccine research can help our children SOAR beyond COVID-19.
What is the HUMMINGBIRD Study?
The HUMMINGBIRD study is testing an investigational vaccine that is designed to prevent coronavirus disease 2019 (COVID-19). The study vaccine is a protein-based (or traditional) vaccine and is not an mRNA vaccine. NVX-CoV2373 has been authorized in various countries for adolescents and adults 12 years of age and older.
Now, researchers are evaluating it for children ages 6 months to 11 years.
To be eligible for this study, your child must:
• Be 6 months to 11 years of age
• Have never been diagnosed with COVID-19
• Not have received a previous vaccine to protect against COVID-19
This is not a complete list of eligibility criteria. The study doctor
will review the full entry criteria for this study with you.
Call (972) 746-2222 to Find Out if Your Child Qualifies for this Study